Key Resources


ASGE Guidelines

ASGE evidence-based guidelines provide clinicians with recommendations for the evaluation, diagnosis, and management of patients undergoing endoscopic procedures of the digestive tract. Guidelines are not a substitute for physicians’ opinion on individual patients. Final decision on an intervention should always be based on local expertise and patient preferences.

All recommendations follow a rigorous process based on a systematic review of medical literature as outlined by the National Academy of Medicine (formerly Institute of Medicine) standards for guideline development.

Whenever possible, guidelines are based on the GRADE (Grading of Recommendation Assessment, Development and Evaluation) methodology.

Panels consist of content experts, stakeholders from other specialties, patient representatives, and members of the ASGE Standards of Practice (SOP) Committee.

Each recommendation is based on consideration of the best medical literature, the balance between risks and benefits, cost-effectiveness, patients’ values, and equity.

Panel members provide ongoing conflict of interest (COI) disclosures, including intellectual conflicts of interest, throughout the development and publication of all guidelines in accordance with the ASGE Policy for Managing Declared Conflicts of Interests.

ASGE strives to provide clinically relevant and practical recommendations, which can help standardize patient care and improve outcomes.

If you have any questions or suggestions, please contact Customer Support at Info@asge.org.

The following information is intended only to provide general information and not as a definitive basis for diagnosis or treatment in any particular case. It is very important that you consult your doctor about your specific condition.

Newly Published

Management of antithrombotic agents for patients undergoing GI endoscopy

Nov 14, 2016, 20:26 PM
This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this text. In preparing this guideline, a search of the medical literature was performed using PubMed and the Cochrane Database, with dates of search from August 1966 to December 2014. Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the guidelines are drafted. Further controlled clinical studies may be needed to clarify aspects of this guideline. This guideline may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence (Table 1).
Ruben D. Acosta, MD , Neena S. Abraham, MD, MSCE, FASGE (invited content expert, ad-hoc member) , Vinay Chandrasekhara, MD , Krishnavel V. Chathadi, MD , Dayna S. Early, MD, FASGE , Mohamad A. Eloubeidi, MD, MHS, FASGE , John A. Evans, MD , Ashley L. Faulx, MD, FASGE , Deborah A. Fisher, MD, MHS, FASGE , Lisa Fonkalsrud, BSN, RN, CGRN , Joo Ha Hwang, MD, PhD, FASGE , Mouen A. Khashab, MD , Jenifer R. Lightdale, MD, MPH, FASGE , V. Raman Muthusamy, MD, FASGE , Shabana F. Pasha, MD , John R. Saltzman, MD, FASGE , Aasma Shaukat, MD, MPH, FASGE , Amandeep K. Shergill, MD , Amy Wang, MD , Brooks D. Cash, MD, FASGE (previous Committee Chair) , John M. DeWitt, MD, FASGE (Chair)
Title : Management of antithrombotic agents for patients undergoing GI endoscopy
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.09.035
Volume : Gastrointest Endosc;2016;83:3-16
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/antithrombotics.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Nov 24, 2015, 00:00 AM
File size :
Number :
ExternalPK : 18517
Categories :
  • Antithrombotic agents
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Preparation for Endoscopy
Tags :
Antithrombotics
GRADE Guidelines

Management of antithrombotic agents for patients undergoing GI endoscopy

Nov 14, 2016, 20:26 PM
This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this text. In preparing this guideline, a search of the medical literature was performed using PubMed and the Cochrane Database, with dates of search from August 1966 to December 2014. Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the guidelines are drafted. Further controlled clinical studies may be needed to clarify aspects of this guideline. This guideline may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence (Table 1).
Ruben D. Acosta, MD , Neena S. Abraham, MD, MSCE, FASGE (invited content expert, ad-hoc member) , Vinay Chandrasekhara, MD , Krishnavel V. Chathadi, MD , Dayna S. Early, MD, FASGE , Mohamad A. Eloubeidi, MD, MHS, FASGE , John A. Evans, MD , Ashley L. Faulx, MD, FASGE , Deborah A. Fisher, MD, MHS, FASGE , Lisa Fonkalsrud, BSN, RN, CGRN , Joo Ha Hwang, MD, PhD, FASGE , Mouen A. Khashab, MD , Jenifer R. Lightdale, MD, MPH, FASGE , V. Raman Muthusamy, MD, FASGE , Shabana F. Pasha, MD , John R. Saltzman, MD, FASGE , Aasma Shaukat, MD, MPH, FASGE , Amandeep K. Shergill, MD , Amy Wang, MD , Brooks D. Cash, MD, FASGE (previous Committee Chair) , John M. DeWitt, MD, FASGE (Chair)
Title : Management of antithrombotic agents for patients undergoing GI endoscopy
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.09.035
Volume : Gastrointest Endosc;2016;83:3-16
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/antithrombotics.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Nov 24, 2015, 00:00 AM
File size :
Number :
ExternalPK : 18517
Categories :
  • Antithrombotic agents
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Preparation for Endoscopy
Tags :
Antithrombotics
Upper GI

Management of antithrombotic agents for patients undergoing GI endoscopy

Nov 14, 2016, 20:26 PM
This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this text. In preparing this guideline, a search of the medical literature was performed using PubMed and the Cochrane Database, with dates of search from August 1966 to December 2014. Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the guidelines are drafted. Further controlled clinical studies may be needed to clarify aspects of this guideline. This guideline may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence (Table 1).
Ruben D. Acosta, MD , Neena S. Abraham, MD, MSCE, FASGE (invited content expert, ad-hoc member) , Vinay Chandrasekhara, MD , Krishnavel V. Chathadi, MD , Dayna S. Early, MD, FASGE , Mohamad A. Eloubeidi, MD, MHS, FASGE , John A. Evans, MD , Ashley L. Faulx, MD, FASGE , Deborah A. Fisher, MD, MHS, FASGE , Lisa Fonkalsrud, BSN, RN, CGRN , Joo Ha Hwang, MD, PhD, FASGE , Mouen A. Khashab, MD , Jenifer R. Lightdale, MD, MPH, FASGE , V. Raman Muthusamy, MD, FASGE , Shabana F. Pasha, MD , John R. Saltzman, MD, FASGE , Aasma Shaukat, MD, MPH, FASGE , Amandeep K. Shergill, MD , Amy Wang, MD , Brooks D. Cash, MD, FASGE (previous Committee Chair) , John M. DeWitt, MD, FASGE (Chair)
Title : Management of antithrombotic agents for patients undergoing GI endoscopy
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.09.035
Volume : Gastrointest Endosc;2016;83:3-16
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/antithrombotics.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Nov 24, 2015, 00:00 AM
File size :
Number :
ExternalPK : 18517
Categories :
  • Antithrombotic agents
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Preparation for Endoscopy
Tags :
Antithrombotics
Lower GI

Management of antithrombotic agents for patients undergoing GI endoscopy

Nov 14, 2016, 20:26 PM
This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this text. In preparing this guideline, a search of the medical literature was performed using PubMed and the Cochrane Database, with dates of search from August 1966 to December 2014. Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the guidelines are drafted. Further controlled clinical studies may be needed to clarify aspects of this guideline. This guideline may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence (Table 1).
Ruben D. Acosta, MD , Neena S. Abraham, MD, MSCE, FASGE (invited content expert, ad-hoc member) , Vinay Chandrasekhara, MD , Krishnavel V. Chathadi, MD , Dayna S. Early, MD, FASGE , Mohamad A. Eloubeidi, MD, MHS, FASGE , John A. Evans, MD , Ashley L. Faulx, MD, FASGE , Deborah A. Fisher, MD, MHS, FASGE , Lisa Fonkalsrud, BSN, RN, CGRN , Joo Ha Hwang, MD, PhD, FASGE , Mouen A. Khashab, MD , Jenifer R. Lightdale, MD, MPH, FASGE , V. Raman Muthusamy, MD, FASGE , Shabana F. Pasha, MD , John R. Saltzman, MD, FASGE , Aasma Shaukat, MD, MPH, FASGE , Amandeep K. Shergill, MD , Amy Wang, MD , Brooks D. Cash, MD, FASGE (previous Committee Chair) , John M. DeWitt, MD, FASGE (Chair)
Title : Management of antithrombotic agents for patients undergoing GI endoscopy
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.09.035
Volume : Gastrointest Endosc;2016;83:3-16
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/antithrombotics.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Nov 24, 2015, 00:00 AM
File size :
Number :
ExternalPK : 18517
Categories :
  • Antithrombotic agents
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Preparation for Endoscopy
Tags :
Antithrombotics
Biliary and Pancreatic Endoscopy

Management of antithrombotic agents for patients undergoing GI endoscopy

Nov 14, 2016, 20:26 PM
This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this text. In preparing this guideline, a search of the medical literature was performed using PubMed and the Cochrane Database, with dates of search from August 1966 to December 2014. Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the guidelines are drafted. Further controlled clinical studies may be needed to clarify aspects of this guideline. This guideline may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence (Table 1).
Ruben D. Acosta, MD , Neena S. Abraham, MD, MSCE, FASGE (invited content expert, ad-hoc member) , Vinay Chandrasekhara, MD , Krishnavel V. Chathadi, MD , Dayna S. Early, MD, FASGE , Mohamad A. Eloubeidi, MD, MHS, FASGE , John A. Evans, MD , Ashley L. Faulx, MD, FASGE , Deborah A. Fisher, MD, MHS, FASGE , Lisa Fonkalsrud, BSN, RN, CGRN , Joo Ha Hwang, MD, PhD, FASGE , Mouen A. Khashab, MD , Jenifer R. Lightdale, MD, MPH, FASGE , V. Raman Muthusamy, MD, FASGE , Shabana F. Pasha, MD , John R. Saltzman, MD, FASGE , Aasma Shaukat, MD, MPH, FASGE , Amandeep K. Shergill, MD , Amy Wang, MD , Brooks D. Cash, MD, FASGE (previous Committee Chair) , John M. DeWitt, MD, FASGE (Chair)
Title : Management of antithrombotic agents for patients undergoing GI endoscopy
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.09.035
Volume : Gastrointest Endosc;2016;83:3-16
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/antithrombotics.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Nov 24, 2015, 00:00 AM
File size :
Number :
ExternalPK : 18517
Categories :
  • Antithrombotic agents
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Preparation for Endoscopy
Tags :
Antithrombotics
Adverse Events

Management of antithrombotic agents for patients undergoing GI endoscopy

Nov 14, 2016, 20:26 PM
This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this text. In preparing this guideline, a search of the medical literature was performed using PubMed and the Cochrane Database, with dates of search from August 1966 to December 2014. Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the guidelines are drafted. Further controlled clinical studies may be needed to clarify aspects of this guideline. This guideline may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence (Table 1).
Ruben D. Acosta, MD , Neena S. Abraham, MD, MSCE, FASGE (invited content expert, ad-hoc member) , Vinay Chandrasekhara, MD , Krishnavel V. Chathadi, MD , Dayna S. Early, MD, FASGE , Mohamad A. Eloubeidi, MD, MHS, FASGE , John A. Evans, MD , Ashley L. Faulx, MD, FASGE , Deborah A. Fisher, MD, MHS, FASGE , Lisa Fonkalsrud, BSN, RN, CGRN , Joo Ha Hwang, MD, PhD, FASGE , Mouen A. Khashab, MD , Jenifer R. Lightdale, MD, MPH, FASGE , V. Raman Muthusamy, MD, FASGE , Shabana F. Pasha, MD , John R. Saltzman, MD, FASGE , Aasma Shaukat, MD, MPH, FASGE , Amandeep K. Shergill, MD , Amy Wang, MD , Brooks D. Cash, MD, FASGE (previous Committee Chair) , John M. DeWitt, MD, FASGE (Chair)
Title : Management of antithrombotic agents for patients undergoing GI endoscopy
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.09.035
Volume : Gastrointest Endosc;2016;83:3-16
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/antithrombotics.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Nov 24, 2015, 00:00 AM
File size :
Number :
ExternalPK : 18517
Categories :
  • Antithrombotic agents
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Preparation for Endoscopy
Tags :
Antithrombotics
Privileging and Credentialing

Management of antithrombotic agents for patients undergoing GI endoscopy

Nov 14, 2016, 20:26 PM
This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this text. In preparing this guideline, a search of the medical literature was performed using PubMed and the Cochrane Database, with dates of search from August 1966 to December 2014. Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the guidelines are drafted. Further controlled clinical studies may be needed to clarify aspects of this guideline. This guideline may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence (Table 1).
Ruben D. Acosta, MD , Neena S. Abraham, MD, MSCE, FASGE (invited content expert, ad-hoc member) , Vinay Chandrasekhara, MD , Krishnavel V. Chathadi, MD , Dayna S. Early, MD, FASGE , Mohamad A. Eloubeidi, MD, MHS, FASGE , John A. Evans, MD , Ashley L. Faulx, MD, FASGE , Deborah A. Fisher, MD, MHS, FASGE , Lisa Fonkalsrud, BSN, RN, CGRN , Joo Ha Hwang, MD, PhD, FASGE , Mouen A. Khashab, MD , Jenifer R. Lightdale, MD, MPH, FASGE , V. Raman Muthusamy, MD, FASGE , Shabana F. Pasha, MD , John R. Saltzman, MD, FASGE , Aasma Shaukat, MD, MPH, FASGE , Amandeep K. Shergill, MD , Amy Wang, MD , Brooks D. Cash, MD, FASGE (previous Committee Chair) , John M. DeWitt, MD, FASGE (Chair)
Title : Management of antithrombotic agents for patients undergoing GI endoscopy
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.09.035
Volume : Gastrointest Endosc;2016;83:3-16
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/antithrombotics.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Nov 24, 2015, 00:00 AM
File size :
Number :
ExternalPK : 18517
Categories :
  • Antithrombotic agents
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Preparation for Endoscopy
Tags :
Antithrombotics
GI Endoscopy Unit Operations

Management of antithrombotic agents for patients undergoing GI endoscopy

Nov 14, 2016, 20:26 PM
This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this text. In preparing this guideline, a search of the medical literature was performed using PubMed and the Cochrane Database, with dates of search from August 1966 to December 2014. Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the guidelines are drafted. Further controlled clinical studies may be needed to clarify aspects of this guideline. This guideline may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence (Table 1).
Ruben D. Acosta, MD , Neena S. Abraham, MD, MSCE, FASGE (invited content expert, ad-hoc member) , Vinay Chandrasekhara, MD , Krishnavel V. Chathadi, MD , Dayna S. Early, MD, FASGE , Mohamad A. Eloubeidi, MD, MHS, FASGE , John A. Evans, MD , Ashley L. Faulx, MD, FASGE , Deborah A. Fisher, MD, MHS, FASGE , Lisa Fonkalsrud, BSN, RN, CGRN , Joo Ha Hwang, MD, PhD, FASGE , Mouen A. Khashab, MD , Jenifer R. Lightdale, MD, MPH, FASGE , V. Raman Muthusamy, MD, FASGE , Shabana F. Pasha, MD , John R. Saltzman, MD, FASGE , Aasma Shaukat, MD, MPH, FASGE , Amandeep K. Shergill, MD , Amy Wang, MD , Brooks D. Cash, MD, FASGE (previous Committee Chair) , John M. DeWitt, MD, FASGE (Chair)
Title : Management of antithrombotic agents for patients undergoing GI endoscopy
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.09.035
Volume : Gastrointest Endosc;2016;83:3-16
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/antithrombotics.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Nov 24, 2015, 00:00 AM
File size :
Number :
ExternalPK : 18517
Categories :
  • Antithrombotic agents
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Preparation for Endoscopy
Tags :
Antithrombotics
Screening and Surveillance in Premalignant Conditions

Management of antithrombotic agents for patients undergoing GI endoscopy

Nov 14, 2016, 20:26 PM
This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this text. In preparing this guideline, a search of the medical literature was performed using PubMed and the Cochrane Database, with dates of search from August 1966 to December 2014. Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the guidelines are drafted. Further controlled clinical studies may be needed to clarify aspects of this guideline. This guideline may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence (Table 1).
Ruben D. Acosta, MD , Neena S. Abraham, MD, MSCE, FASGE (invited content expert, ad-hoc member) , Vinay Chandrasekhara, MD , Krishnavel V. Chathadi, MD , Dayna S. Early, MD, FASGE , Mohamad A. Eloubeidi, MD, MHS, FASGE , John A. Evans, MD , Ashley L. Faulx, MD, FASGE , Deborah A. Fisher, MD, MHS, FASGE , Lisa Fonkalsrud, BSN, RN, CGRN , Joo Ha Hwang, MD, PhD, FASGE , Mouen A. Khashab, MD , Jenifer R. Lightdale, MD, MPH, FASGE , V. Raman Muthusamy, MD, FASGE , Shabana F. Pasha, MD , John R. Saltzman, MD, FASGE , Aasma Shaukat, MD, MPH, FASGE , Amandeep K. Shergill, MD , Amy Wang, MD , Brooks D. Cash, MD, FASGE (previous Committee Chair) , John M. DeWitt, MD, FASGE (Chair)
Title : Management of antithrombotic agents for patients undergoing GI endoscopy
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.09.035
Volume : Gastrointest Endosc;2016;83:3-16
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/antithrombotics.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Nov 24, 2015, 00:00 AM
File size :
Number :
ExternalPK : 18517
Categories :
  • Antithrombotic agents
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Preparation for Endoscopy
Tags :
Antithrombotics
Procedural Management in Endoscopy

Management of antithrombotic agents for patients undergoing GI endoscopy

Nov 14, 2016, 20:26 PM
This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this text. In preparing this guideline, a search of the medical literature was performed using PubMed and the Cochrane Database, with dates of search from August 1966 to December 2014. Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the guidelines are drafted. Further controlled clinical studies may be needed to clarify aspects of this guideline. This guideline may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence (Table 1).
Ruben D. Acosta, MD , Neena S. Abraham, MD, MSCE, FASGE (invited content expert, ad-hoc member) , Vinay Chandrasekhara, MD , Krishnavel V. Chathadi, MD , Dayna S. Early, MD, FASGE , Mohamad A. Eloubeidi, MD, MHS, FASGE , John A. Evans, MD , Ashley L. Faulx, MD, FASGE , Deborah A. Fisher, MD, MHS, FASGE , Lisa Fonkalsrud, BSN, RN, CGRN , Joo Ha Hwang, MD, PhD, FASGE , Mouen A. Khashab, MD , Jenifer R. Lightdale, MD, MPH, FASGE , V. Raman Muthusamy, MD, FASGE , Shabana F. Pasha, MD , John R. Saltzman, MD, FASGE , Aasma Shaukat, MD, MPH, FASGE , Amandeep K. Shergill, MD , Amy Wang, MD , Brooks D. Cash, MD, FASGE (previous Committee Chair) , John M. DeWitt, MD, FASGE (Chair)
Title : Management of antithrombotic agents for patients undergoing GI endoscopy
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.09.035
Volume : Gastrointest Endosc;2016;83:3-16
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/antithrombotics.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Nov 24, 2015, 00:00 AM
File size :
Number :
ExternalPK : 18517
Categories :
  • Antithrombotic agents
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Preparation for Endoscopy
Tags :
Antithrombotics
Miscellaneous

Management of antithrombotic agents for patients undergoing GI endoscopy

Nov 14, 2016, 20:26 PM
This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this text. In preparing this guideline, a search of the medical literature was performed using PubMed and the Cochrane Database, with dates of search from August 1966 to December 2014. Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the guidelines are drafted. Further controlled clinical studies may be needed to clarify aspects of this guideline. This guideline may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence (Table 1).
Ruben D. Acosta, MD , Neena S. Abraham, MD, MSCE, FASGE (invited content expert, ad-hoc member) , Vinay Chandrasekhara, MD , Krishnavel V. Chathadi, MD , Dayna S. Early, MD, FASGE , Mohamad A. Eloubeidi, MD, MHS, FASGE , John A. Evans, MD , Ashley L. Faulx, MD, FASGE , Deborah A. Fisher, MD, MHS, FASGE , Lisa Fonkalsrud, BSN, RN, CGRN , Joo Ha Hwang, MD, PhD, FASGE , Mouen A. Khashab, MD , Jenifer R. Lightdale, MD, MPH, FASGE , V. Raman Muthusamy, MD, FASGE , Shabana F. Pasha, MD , John R. Saltzman, MD, FASGE , Aasma Shaukat, MD, MPH, FASGE , Amandeep K. Shergill, MD , Amy Wang, MD , Brooks D. Cash, MD, FASGE (previous Committee Chair) , John M. DeWitt, MD, FASGE (Chair)
Title : Management of antithrombotic agents for patients undergoing GI endoscopy
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.09.035
Volume : Gastrointest Endosc;2016;83:3-16
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/antithrombotics.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Nov 24, 2015, 00:00 AM
File size :
Number :
ExternalPK : 18517
Categories :
  • Antithrombotic agents
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Preparation for Endoscopy
Tags :
Antithrombotics
Guidelines in Spanish

Management of antithrombotic agents for patients undergoing GI endoscopy

Nov 14, 2016, 20:26 PM
This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this text. In preparing this guideline, a search of the medical literature was performed using PubMed and the Cochrane Database, with dates of search from August 1966 to December 2014. Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the guidelines are drafted. Further controlled clinical studies may be needed to clarify aspects of this guideline. This guideline may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence (Table 1).
Ruben D. Acosta, MD , Neena S. Abraham, MD, MSCE, FASGE (invited content expert, ad-hoc member) , Vinay Chandrasekhara, MD , Krishnavel V. Chathadi, MD , Dayna S. Early, MD, FASGE , Mohamad A. Eloubeidi, MD, MHS, FASGE , John A. Evans, MD , Ashley L. Faulx, MD, FASGE , Deborah A. Fisher, MD, MHS, FASGE , Lisa Fonkalsrud, BSN, RN, CGRN , Joo Ha Hwang, MD, PhD, FASGE , Mouen A. Khashab, MD , Jenifer R. Lightdale, MD, MPH, FASGE , V. Raman Muthusamy, MD, FASGE , Shabana F. Pasha, MD , John R. Saltzman, MD, FASGE , Aasma Shaukat, MD, MPH, FASGE , Amandeep K. Shergill, MD , Amy Wang, MD , Brooks D. Cash, MD, FASGE (previous Committee Chair) , John M. DeWitt, MD, FASGE (Chair)
Title : Management of antithrombotic agents for patients undergoing GI endoscopy
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.09.035
Volume : Gastrointest Endosc;2016;83:3-16
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/antithrombotics.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Nov 24, 2015, 00:00 AM
File size :
Number :
ExternalPK : 18517
Categories :
  • Antithrombotic agents
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Preparation for Endoscopy
Tags :
Antithrombotics

In Progress Guidelines

ASGE Guideline for the Management of Post-Liver Transplant Biliary Strictures

Estimated 2022

ASGE Guideline on the Prevention of Post-ERCP Pancreatitis

Estimated 2022

ASGE Guideline on the Role of Ergonomics to Prevent Injuries for the Endoscopist

Estimated 2022

ASGE guideline on the role of endoscopy in the diagnosis of biliary strictures

Estimated 2022

ASGE Guideline on the Role of Endoscopic Submucosal Dissection in the Management of Esophageal and Gastric Mucosal Neoplasia

Estimated 2022

ASGE Thursday Night Lights

Quality in Endoscopy

Quality documents define the indicators of high-quality endoscopy and how to measure it. ASGE quality indicators are based on a rigorous review process which results in valid metrics for evaluating GI endoscopic procedures. 

Quality in Endoscopy

Management of antithrombotic agents for patients undergoing GI endoscopy

Nov 14, 2016, 20:26 PM
This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this text. In preparing this guideline, a search of the medical literature was performed using PubMed and the Cochrane Database, with dates of search from August 1966 to December 2014. Additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When limited or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the guidelines are drafted. Further controlled clinical studies may be needed to clarify aspects of this guideline. This guideline may be revised as necessary to account for changes in technology, new data, or other aspects of clinical practice. The recommendations were based on reviewed studies and were graded on the strength of the supporting evidence (Table 1).
Ruben D. Acosta, MD , Neena S. Abraham, MD, MSCE, FASGE (invited content expert, ad-hoc member) , Vinay Chandrasekhara, MD , Krishnavel V. Chathadi, MD , Dayna S. Early, MD, FASGE , Mohamad A. Eloubeidi, MD, MHS, FASGE , John A. Evans, MD , Ashley L. Faulx, MD, FASGE , Deborah A. Fisher, MD, MHS, FASGE , Lisa Fonkalsrud, BSN, RN, CGRN , Joo Ha Hwang, MD, PhD, FASGE , Mouen A. Khashab, MD , Jenifer R. Lightdale, MD, MPH, FASGE , V. Raman Muthusamy, MD, FASGE , Shabana F. Pasha, MD , John R. Saltzman, MD, FASGE , Aasma Shaukat, MD, MPH, FASGE , Amandeep K. Shergill, MD , Amy Wang, MD , Brooks D. Cash, MD, FASGE (previous Committee Chair) , John M. DeWitt, MD, FASGE (Chair)
Title : Management of antithrombotic agents for patients undergoing GI endoscopy
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.09.035
Volume : Gastrointest Endosc;2016;83:3-16
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/antithrombotics.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Nov 24, 2015, 00:00 AM
File size :
Number :
ExternalPK : 18517
Categories :
  • Antithrombotic agents
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Preparation for Endoscopy
Tags :
Antithrombotics

Technology Assessments

Technology evaluations provide a review of existing, new, or emerging endoscopic technologies that have an impact on the practice of GI endoscopy. Evaluations are based on a literature review and a search of the MAUDE (U.S. Food and Drug Administration Center for Devices and Radiological Health) database to identify the reported adverse events of a given technology. When financial guidance is indicated, the most recent coding data and list prices at the time of publication are provided.

Technology Assessments